Explore more publications!

Florida Culture Times Press Releases

Labels On
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
Info
Aubuchon Homes Returns as Premier Artist Area Sponsor for 41st Annual Cape Coral Art Festival
Secura Bio Announces Poster Presentation Highlighting Extended Follow Up Analyses from Phase 2 PRIMO Trial at the 2025 American Society of Hematology Meeting
Lakeland Palms Shine in All Florida Pickleball League, Winning 3 of 5 Stops and Celebrating Player’s PPA Contract
IT Fusion, LLC Recognized with 2025 Best of Florida Award
BrickTech Publishes Article Identifying Signs Small Businesses Need Upgraded IT Support
Reclaim.org Introduced as Florida’s Central Resource for Unclaimed Money Recovery
Cape Coral Art Festival Celebrates 41 Years of Art, Community, and Giving Back
Tessera Therapeutics to Present New Preclinical Data From In Vivo Programs for Sickle Cell Disease and T Cell Therapies at the 67th American Society of Hematology Annual Meeting
Arvinas to Present Preclinical Data for ARV-393 at the 2025 American Society of Hematology (ASH) Annual Meeting
NextNRG Secures 28-Year Microgrid Power Purchase Agreement with California Healthcare Facility, Expanding into a Multi-Billion-Dollar Healthcare Resilience Market
Zūm Rails Replaces Stripe to Power All Payment Transactions  for Mobile Pet Services Chain
Marine Lifestyle Company Reimagines Boat Ownership on Florida's Gulf Coast
AWARD-WINNING ST. AUGUSTINE CELTIC MUSIC & HERITAGE FESTIVAL RETURNS MARCH 14-15
Senti Bio to Present Updated Clinical Results of First-in-Class Logic Gated CD33/FLT3 Cell Therapy, SENTI-202, at the American Society of Hematology (ASH) Annual Meeting 2025
Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2025
Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual Meeting
March Biosciences Announces Oral Presentation of MB-105 Interim Phase 2 Clinical Data at American Society of Hematology Annual Meeting
Florida Trend Releases the 2025 Florida 500: Florida’s Most Influential Business Leaders
SELLAS Life Sciences Announces Presentation of Phase 2 Data of SLS009 in Combination with Azacitidine and Venetoclax in Relapsed/Refractory AML with MDS-Related Changes (AML-MR) at the 2025 American Society of Hematology (ASH) Annual Meeting
EDWARD Transportation Earns 2025 Best of Florida Award

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions